India antidepressant market grows to Rs 2,842 crore, but unit volume declines despite price inflation

India's antidepressant and mood-drug market grew 8.63% to Rs 2,842.1 crore in the 12 months ended September 2026, yet unit sales declined 0.76% over the same period. Doctors caution the figures must be viewed against unmet mental health treatment needs. For digital mental health builders: pricing is rising but patient volume is stagnant, suggesting payers (insurance, employers) are squeezing reimbursement while true patient needs remain underserved—you have a window to capture price-insensitive segments (premium corporate wellness, direct-to-consumer).

Source: ET HealthWorld ↗